Bug#589168: marked as done (ITP: oxygen-molecule -- KDE & GTK+ unified theme)
Your message dated Sat, 23 Oct 2010 10:54:52 +0200
with message-id <cc3d7b98ff957f3217b6e3bf3b3d8c72@mb8-2.1blu.de>
and subject line Re: ITP: oxygen-molecule -- KDE & GTK+ unified theme
has caused the Debian Bug report #589168,
regarding ITP: oxygen-molecule -- KDE & GTK+ unified theme
to be marked as done.
This means that you claim that the problem has been dealt with.
If this is not the case it is now your responsibility to reopen the
Bug report if necessary, and/or fix the problem forthwith.
(NB: If you are a system administrator and have no idea what this
message is talking about, this may indicate a serious mail system
misconfiguration somewhere. Please contact owner@bugs.debian.org
immediately.)
--
589168: http://bugs.debian.org/cgi-bin/bugreport.cgi?bug=589168
Debian Bug Tracking System
Contact owner@bugs.debian.org with problems
--- Begin Message ---
- To: submit@bugs.debian.org
- Subject: ITP: oxygen-molecule -- KDE & GTK+ unified theme
- From: Matthias Klumpp <matthias@nlinux.org>
- Date: Thu, 15 Jul 2010 16:07:58 +0200
- Message-id: <36d2555e625a8a0dc0c244a29457e8d5@mb8-2.1blu.de>
Package: wnpp
Severity: wishlist
Owner: !
* Package name : oxygen-molecule
Version : 3.2
Upstream Authors: S. Christian Collins
* URL : http://projectm.sf.net
* License : GPL
Description : Uniform visual appearance for KDE4
Oxygen-Molecule is a theme for GTK+ applications to
provide
a uniform look when used under the KDE desktop
environment.
It was originally based on the kde4.2-oxygen
--- End Message ---
--- Begin Message ---
- To: <589168-done@bugs.debian.org>
- Subject: Re: ITP: oxygen-molecule -- KDE & GTK+ unified theme
- From: Matthias Klumpp <matthias@nlinux.org>
- Date: Sat, 23 Oct 2010 10:54:52 +0200
- Message-id: <cc3d7b98ff957f3217b6e3bf3b3d8c72@mb8-2.1blu.de>
- In-reply-to: <55e5a6a959457adb2592a7dac1d3c655@mb8-2.1blu.de>
- References: <55e5a6a959457adb2592a7dac1d3c655@mb8-2.1blu.de>
This package has been superseded by gtk2-engine-oxygen, see ITP #601046
--- End Message ---
Reply to: